Amphastar Pharmaceuticals (AMPH) Stock Looks About Right After A 42% Slide

Amphastar Pharmaceuticals has seen its share price move around in recent years, which puts a spotlight on whether the current US$25.87 level lines up with what its earnings really support. For anyone tracking the drug maker today, the key issue is how that recent price path squares with the profits the business is generating. The stock has declined 41.9% over the past 3 years, which raises the question of whether earnings now fully explain that reset in market expectations. The business...